pharma · BPD - Bronchopulmonary Dysplasia
Children's Hospital Zhejiang
The Children's Hospital of Zhejiang University School of Medicine
Children's Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include BPD - Bronchopulmonary Dysplasia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent r
CN HQ
109 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 109
- Programs
- 1
- Drugs
- 2
- Patents
- 0
MSC
Phase 2 · small molecule · BPD - Bronchopulmonary Dysplasia
MSC for BPD - Bronchopulmonary Dysplasia is a Phase 2 program (small_molecule) at The Children's Hospital of Zhejiang University School of Medicine with 1 ClinicalTrials.gov record(s).
Internal code 2019-SC-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- BPD - Bronchopulmonary Dysplasia
- Status
- active
- Trials
- 1